Signs of gestational diabetes in third trimester
Pro Research Analysisby 
Searched over 200M research papers
Signs of Gestational Diabetes in the Third Trimester
Gestational diabetes mellitus (GDM) is a condition characterized by glucose intolerance that is first recognized during pregnancy. It typically manifests in the second or third trimester and can have significant implications for both maternal and fetal health. Understanding the signs and outcomes of GDM diagnosed in the third trimester is crucial for timely intervention and management.
Increased Risk of Macrosomia and Cesarean Section
One of the primary signs of gestational diabetes diagnosed in the third trimester is an increased risk of macrosomia, which refers to a newborn with an excessive birth weight. Studies have shown that women diagnosed with GDM in the third trimester have a higher incidence of delivering large-for-gestational-age infants compared to those diagnosed earlier . This condition often necessitates cesarean section deliveries due to the complications associated with larger infants, such as shoulder dystocia .
Morbid Obesity and Its Implications
Morbid obesity, defined as a body mass index (BMI) of 35 kg/m² or higher, is more prevalent among women diagnosed with GDM in the third trimester. This condition exacerbates the risk of adverse pregnancy outcomes, including the likelihood of cesarean sections and complications during delivery. The correlation between third-trimester GDM and morbid obesity underscores the importance of monitoring and managing weight gain during pregnancy.
Lower Incidence of Hypertensive Disorders
Interestingly, women diagnosed with GDM in the third trimester tend to have a lower incidence of hypertensive disorders of pregnancy, such as preeclampsia, compared to those diagnosed in the second trimester. This finding suggests that the timing of GDM diagnosis may influence the type of complications that arise, with earlier diagnoses being more associated with hypertensive issues.
Neonatal Complications
Neonatal complications are also a concern with third-trimester GDM. Infants born to mothers with late-onset GDM are at a higher risk of having a low 5-minute Apgar score, which is an indicator of the newborn's health immediately after birth. Additionally, these infants may require emergent cesarean deliveries due to complications arising from the mother's glucose intolerance.
Metabolic Changes and Biomarkers
Metabolic changes are significant in pregnancies affected by GDM. Studies have identified alterations in metabolites involved in fatty acid oxidation and purine degradation in women with GDM, which can be detected through metabolomic analysis. These metabolic changes provide insights into the pathophysiology of GDM and highlight the importance of monitoring metabolic health throughout pregnancy.
Conclusion
Gestational diabetes diagnosed in the third trimester presents distinct challenges and risks, including increased rates of macrosomia, cesarean sections, and specific neonatal complications. While the incidence of hypertensive disorders may be lower, the overall impact on maternal and fetal health necessitates careful monitoring and management. Understanding these signs and outcomes can help healthcare providers implement timely interventions to mitigate risks associated with late-onset GDM.
Sources and full results
Most relevant research papers on this topic